Having trouble finding Abiraterone at your pharmacy? Learn why this prostate cancer medication can be hard to find in 2026 and what steps you can take.
You got your prescription for Abiraterone, called your pharmacy, and heard the words no patient wants to hear: "We don't have it in stock." If this has happened to you, take a deep breath — you're not alone, and there are steps you can take to get your medication.
Abiraterone (sold under the brand names Zytiga and Yonsa) is a critical medication for men battling prostate cancer. When you can't find it, the stress is real. In this article, we'll explain why Abiraterone can be difficult to find and what you can do about it.
Abiraterone Acetate is a prescription medication classified as a CYP17 inhibitor. It works by blocking an enzyme called CYP17, which your body needs to produce testosterone and other androgens. Since prostate cancer cells often rely on these hormones to grow, Abiraterone essentially cuts off their fuel supply.
The FDA has approved Abiraterone for two main uses:
It's taken as a daily oral tablet (usually 1,000 mg) in combination with Prednisone. For more details on how the drug works, check out our guide on how Abiraterone works.
There are several reasons you might struggle to fill your Abiraterone prescription in 2026:
Abiraterone isn't a medication that every neighborhood pharmacy keeps on its shelves. As a specialty oncology drug, many retail pharmacies simply don't stock it. They may need to special-order it, which can take days — time you may not want to waste when you need your cancer treatment.
Many specialty medications like Abiraterone are distributed through a smaller network of specialty pharmacies rather than the broader retail pharmacy system. Your oncologist may need to send your prescription to a specific specialty pharmacy, and not all of these are located near you.
Even when a pharmacy has Abiraterone in stock, insurance-related hurdles can make it feel impossible to get. Many insurance plans require prior authorization before they'll cover Abiraterone, and some require step therapy — meaning you may need to try other treatments first. These processes can take days or even weeks to resolve.
Without insurance, Abiraterone can cost anywhere from $90 to over $9,000 per month depending on the version and pharmacy. Even with insurance, specialty tier copays can be significant. When patients can't afford their copays, pharmacies may not keep as much stock on hand. For tips on reducing costs, see our guide on how to save money on Abiraterone.
If you're having trouble finding Abiraterone, here are practical steps you can take today:
The fastest way to find Abiraterone in stock near you is to use Medfinder. It lets you search for your medication and see which pharmacies near you actually have it available — saving you the frustration of calling pharmacy after pharmacy.
Talk to your oncologist's office about which specialty pharmacies they work with. Many cancer centers have relationships with specialty pharmacies that reliably stock Abiraterone and can ship it directly to your home.
If prior authorization is causing delays, call your insurance company directly to check on the status. Your oncologist's office can also help expedite the process by submitting a peer-to-peer review or appeal.
Independent pharmacies are sometimes more willing to order specialty medications and may offer more competitive pricing. Don't overlook them as a potential source. For more tips, read our article on how to find Abiraterone in stock near you.
If cost is the barrier, look into copay assistance. The Apotex Instant Savings Card lets eligible patients pay as little as $5 per month, and the Amneal Copay Card offers copays as low as $10 per month. These programs can make the difference between getting your medication or going without.
If you truly cannot find or afford Abiraterone, talk to your oncologist. There are alternative medications in the same therapeutic class, including Enzalutamide (Xtandi), Apalutamide (Erleada), and Darolutamide (Nubeqa). Your doctor can help determine if a switch makes sense for your situation.
Finding Abiraterone shouldn't be harder than fighting cancer. While there are real challenges — from specialty distribution to insurance hurdles to cost barriers — there are also real solutions. Start with Medfinder to locate pharmacies with stock near you, explore copay assistance programs, and don't hesitate to lean on your oncology team for help navigating the system.
Your treatment shouldn't wait. Take action today.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.
%2C%20Color%3DOriginal.png)
